Wednesday, May 14, 2025
HomeIndustriesBiotechnology

Biotechnology

Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T

Precigen, Inc, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced the amendment...

Read Magazine’s Weekly Roundup Featuring NASA, Carvana, Patriot’s, Nextracker and more!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Applied DNA Achieves Milestone for Large-Scale linearDNA Production, Delivers Largest Single Shipment by Volume to Date

Applied DNA Sciences, Inc, a leader in PCR-based DNA technologies, announced that it has established a new high bar for the production of DNA...

Thermo Fisher Scientific and Arsenal Biosciences Form Collaboration to Support Clinical Manufacturing of Autologous T-Cell Therapies

Thermo Fisher Scientific, the global leader in serving science, and Arsenal Biosciences, Inc. , a cell therapy clinical development company, to develop novel chimeric...

Xeris Biopharma Appoints Ricki Fairley to Board of Directors

Xeris Biopharma Holdings , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic...
0FansLike
0FollowersFollow
spot_img

Hot Topics